Calculate your body mass index (BMI)

Weight

Feet

Inches

Your BMI

Back to list

High Cholesterol Male Patients 243965


Study Dates: 14/11/19 - 25/1/20

Trial Number

243965

Group

●  Smoking (Yes)
●  Smoking (No)
●  Cholesterol

Compensation

Up to: $3,920

Gender

Male, Smoker, Non-Smoker

Age

18-70

Additional Information

You will need to attend three screening visits for this study, each of which you will be compensated for.

We are recruiting patients who are taking either Atorvastatin or Rosuvastatin. Other medications and ailments, such as diabetes, are permissible on this study.

The study consists of a nine night stay in our unit followed by eight outpatient visits. The total duration of the study from admission to final visit is 71 days.

Light smokers of five or less cigarettes (or the nicotine equivalent) per day, as well as non-smokers, are welcome to screen for this study.

The start dates for the study at the moment are shown below:

-Cohort 4a - Admission 14th November 2019

-Cohort 4b - Admission 18th November 2019

-Cohort 4c - Admission 25th November 2019

Please call recruitment on 01895 614 888 for more information.

Details

The Study drug is being developed to treat patients who suffer from hypercholesterolemia, more commonly known as high cholesterol.

This trial is looking to determine,

The safety and tolerability of the drug in humans.

How it is distributed, broken down and excreted from the body.

The effect of the drug on blood cholesterol levels.

The drug will be administered as a subcutaneous injection. A single, or several, injections with a small needle just under the skin of the stomach.